|
|
|
Insider
Information: |
Gadicke Ansbert |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
30,197 |
|
Indirect Shares
|
56,162,356 |
|
|
Direct
Value |
$22,799 |
|
|
Indirect Value
|
$188,066,302 |
|
|
Total
Shares |
56,192,553 |
|
|
Total
Value |
$188,089,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
Former 10% Owner |
2004-07-02 |
0 |
2004-09-13 |
475,026 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
Director, 10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
Radius Health Inc. |
RDUS |
Director |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Former 10% Owner |
|
0 |
2013-03-11 |
2,790,479 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2012-02-01 |
0 |
2012-02-01 |
3,740 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
2012-06-05 |
0 |
2012-07-09 |
1,275,886 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
|
0 |
2014-02-10 |
2,413,819 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,388,165 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
8,422,847 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
Director, 10% Owner |
2019-02-19 |
0 |
2023-06-01 |
0 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2021-07-12 |
3,882,485 |
Premium* |
|
Allovir Inc |
ALVR |
Director, 10% Owner |
2022-07-28 |
30,197 |
2022-07-28 |
16,674,766 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
10% Owner |
2020-09-21 |
0 |
2020-09-21 |
91,081 |
Premium* |
|
Oncorus, Inc. |
ONCR |
10% Owner |
|
0 |
2020-10-06 |
2,377,025 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-02 |
4 |
AS |
$31.83 |
$197,999 |
I/I |
(6,215) |
4,202,574 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-25 |
4 |
AS |
$32.87 |
$216,094 |
I/I |
(6,572) |
4,272,659 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-27 |
4 |
AS |
$32.81 |
$262,141 |
I/I |
(7,951) |
4,240,672 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-06 |
4 |
S |
$0.29 |
$2,436 |
I/I |
(8,400) |
3,783,185 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-18 |
4 |
AS |
$33.46 |
$302,963 |
I/I |
(9,000) |
4,035,250 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-20 |
4 |
AS |
$34.66 |
$345,428 |
I/I |
(9,957) |
4,604,100 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-01 |
4 |
S |
$17.95 |
$179,500 |
I/I |
(10,000) |
3,492,993 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-13 |
4 |
S |
$22.30 |
$223,000 |
I/I |
(10,000) |
1,824,423 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-19 |
4 |
S |
$0.29 |
$3,480 |
I/I |
(12,000) |
3,759,735 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-04 |
4 |
AS |
$30.80 |
$394,522 |
I/I |
(12,736) |
4,167,542 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-19 |
4 |
AS |
$34.23 |
$466,965 |
I/I |
(13,543) |
4,614,057 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-17 |
4 |
S |
$22.44 |
$305,216 |
I/I |
(13,599) |
1,810,824 |
|
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-01 |
4 |
AS |
$32.50 |
$492,083 |
I/I |
(15,141) |
4,208,789 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
16,203 |
1,849,800 |
|
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-28 |
4 |
AS |
$34.06 |
$564,042 |
I/I |
(16,500) |
3,947,264 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-28 |
4 |
AS |
$32.67 |
$546,961 |
I/I |
(16,742) |
4,223,930 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-02-19 |
4 |
S |
$20.00 |
$346,680 |
I/I |
(17,334) |
4,150,571 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2012-06-28 |
4 |
S |
$0.29 |
$5,655 |
I/I |
(19,500) |
3,750,235 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-05-27 |
4 |
S |
$17.85 |
$359,672 |
I/I |
(20,154) |
3,506,943 |
|
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(21,834) |
4,627,600 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-24 |
4 |
AS |
$33.30 |
$757,540 |
I/I |
(22,200) |
4,279,231 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-03 |
4 |
AS |
$31.92 |
$711,688 |
I/I |
(22,296) |
4,180,278 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-25 |
4 |
AS |
$33.51 |
$756,220 |
I/I |
(22,567) |
3,963,764 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-06-07 |
4 |
AS |
$30.74 |
$755,401 |
I/I |
(23,117) |
4,144,425 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
10% Owner |
|
2021-05-18 |
4 |
AS |
$33.90 |
$799,571 |
I/I |
(23,404) |
4,649,434 |
0 |
- |
|
108 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|